Status:
COMPLETED
PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.
Lead Sponsor:
Jules Bordet Institute
Conditions:
Colorectal Cancer Metastatic
Early Response Evaluation
Eligibility:
All Genders
18+ years
Brief Summary
Study hypothesis : early decrease in fdg-pet measured SUV max after 1 cycle of chemotherapy can accurately predict response of chemotherapy as assessed by conventional radiology after 3 cycles of chem...
Detailed Description
statistical hypothesis : Sample size calculation for FDG-PET in metastatic patients. In the paper of Cascini et al. \[1\], they have 18 patients with a TRG response (TRG = Tumor Regression Grade) and...
Eligibility Criteria
Inclusion
- advanced colorectal cancer
- evaluable disease
- signed informed consent
Exclusion
- no other cancer
- no other life-threatening condition
- unwillingness or inability to sign informed consent
- active cerebral metastasis
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00741481
Start Date
June 1 2006
End Date
July 1 2010
Last Update
February 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Jules Bordet, Université Libre de Bruxelles
Brussels, Belgium, 1190